Genentech

gene.com · South San Francisco, United States of America

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes biologic therapies, primarily for oncology, immunology, and neuroscience indications. It conducts research and clinical development in-house and generates revenue through the sale of prescription drugs and biologic treatments worldwide, largely via its parent company Roche’s commercial infrastructure. The company also partners with other biopharmaceutical firms and research institutions on drug discovery and development programs.

Revenue
$26.0B
Employees
14,000
Founded
1976
Headquarters
South San Francisco, United States of America

What 8 Arbolus experts think of Genentech

NPS distribution shows a concentration of high scores (9-10) from User roles in public safety and non-healthcare settings, but lower to moderate scores from Influencers in core healthcare and research (ranging from 5 to 9). Renewal intent is strongly split: none of the high spenders are confident in renewal, with 100% uncertainty at the Pilot stage. Implementation stickiness is limited, with most customers in Pilot or uncertain stages, and only three in post-implementation. Major themes include positive front-line sentiment but cautious institutional commitment.Overall Customer Sentiment: Neutral

Who reviewed Genentech

Total customers 8 6 current · 2 former
Reviews growth +7 in six months
Seniority of respondents
  • C-Suite 67% (5)
  • Director 33% (3)
Not specified C-Suite NPS 8 Not renewing
Other Analyst Not specified NPS 9 Undecided
Operations Manager Director NPS 10

Employer names and spend open once the report publishes.

Tell us when the Genentech report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

25 Net Promoter Score, from 8 scored reviews
  • Promoters 4
  • Passives 2
  • Detractors 2

Cumulative NPS by month

+0 over 6 months
  • Jan 7
  • Feb 6
  • Apr 7
  • May 8
  • Jun 8
  • Jul 7

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 25 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 0%
  • Will renew 0
  • Undecided 2
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 2 answers
  • Not specified 0% 1 answer
  • 8/10 Average score from undecided customers
  • 8/10 Average score from customers not renewing

For people who use Genentech

Do you use Genentech at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 8 customers of Genentech have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.